Metabolic Integration II: Integrative Physiology and Clinical Case Applications

Metabolic Transitions and Regulatory Integration

• The integration of metabolic processes occurs across different nutritional states:   - Fed state (postprandial)   - Fasting state (basal rate or overnight fast)   - Starvation (prolonged fasting)   - Re-fed state (recovery from fasting/starvation)

• Adaptive metabolic regulation is observed in various physiological states, such as lifestyle modifications, pregnancy, and exercise.

• Malonyl CoA plays a critical role in regulating $\beta$-oxidation:   - It is the product of the committed step in fatty acid synthesis.   - It exerts a regulatory effect by inactivating carnitine palmitoyltransferase 1 ($\text{CPT1}$), which prevents the entry of free fatty acids into the mitochondria for oxidation.

• Insulin Resistance in Muscle and Adipocytes:   - Both tissues contain $\text{GLUT4}$ transporters for taking up glucose from the blood.   - Overweight or obese individuals often start an inflammatory process (not infectious) related to how organs handle excess substrate (glucose).   - This inflammatory state leads to altered handling of substrates, marking the pathological start of insulin resistance.

Case Study 1: Obesity and Metabolic Dysfunction

• Patient Profile (Shakee Jolly Bels): 30-year-old female, weight = $120\,\text{kg}$, height = $1.65\,\text{m}$, $BP = 160/100\,\text{mmHg}$. Elevated blood sugar, $\text{VLDL}$, and $\text{LDL}$.

• Molecular Mechanisms of Metabolic Control:   - MCP-1 (Monocyte Chemoattractant Protein-1) and $\text{TNF-}\alpha$ (Tumor Necrosis Factor-alpha): These inflammatory cytokines produced by hypertrophied adipocytes worsen insulin sensitivity and blood glucose control.   - Bariatric Surgery: Evaluated for its molecular effects on satiety hormones (such as ghrelin) and fat loss through reduced gastric capacity and altered nutrient absorption in the distal stomach/duodenum.

Liver Metabolism in the Well-Fed State

• Glucose 6-Phosphate ($\text{G6-P}$):   - Once trapped in the cell, it is phosphorylated by glucokinase in the liver (an irreversible enzyme requiring $1\,\text{ATP}$).   - Glycolysis: Oxidizes $\text{G6-P}$ to pyruvate, which enters mitochondria for conversion to energy and excess acetyl-CoA.   - Citrate Translocation: Mitochondrial acetyl-CoA translocates to the cytosol as citrate, which is cleaved to form cytosolic acetyl-CoA for fatty acid and cholesterol synthesis.   - Pentose Phosphate Pathway ($\text{PPP}$): Acts as a source for ribose 5-phosphate (nucleotide component) and the reducing equivalent ($\text{NADPH}$) for de novo synthesis.

• Amino Acid Metabolism:   - Used for liver/plasma protein synthesis, nucleotides, hormones, and porphyrins.   - Carbon skeletons can be deaminated via the urea cycle to form pyruvate.   - Alanine from muscle (glucose-alanine cycle) is converted to pyruvate and then acetyl-CoA.

• Free Fatty Acid ($\text{FFA}$) Metabolism:   - In the fed state, acetyl-CoA leads to citrate/TCA cycle activity or cytosolic translocation for steroid and bile salt formation.

• Alcohol/Ketogenesis Note: Chronic alcohol ingestion (or diabetic ketoacidosis) with high $\text{NADH}$ levels can drive acetyl-CoA toward ketone body formation.

Hormonal Regulation of Glucose Homeostatis

• Insulin Effects (Table 1):   - $\uparrow$ Glucose uptake (muscle, adipose) via $\uparrow \text{GLUT4}$.   - $\uparrow$ Glucose uptake (liver) via $\uparrow \text{Glucokinase expression}$.   - $\uparrow$ Glycogen synthesis via $\uparrow \text{Glycogen synthase}$.   - $\downarrow$ Glycogen breakdown via $\downarrow \text{Glycogen phosphorylase}$ (induced by phosphatase-mediated dephosphorylation).   - $\uparrow$ Glycolysis via $\uparrow \text{PFK-1}$ (stimulated by $\text{PFK-2}$) and $\uparrow \text{PDH}$.   - $\uparrow$ Fatty acid synthesis (liver) via $\uparrow \text{ACC1}$.   - $\uparrow$ $\text{TAG}$ synthesis (adipose) via $\uparrow \text{LPL}$ (Lipoprotein Lipase).

• Glucagon Effects (Table 2):   - $\uparrow$ Glycogen breakdown ($\uparrow \text{Glycogen phosphorylase}$ via $\text{GPCR/PKA}$).   - $\downarrow$ Glycogen synthesis (phosphorylates and inactivates $\text{Glycogen synthase}$).   - $\downarrow$ Glycolysis (decreased $\text{PFK-1}$ activity to conserve glucose for other tissues).   - $\uparrow$ Gluconeogenesis ($\uparrow \text{FBPase}$, $\uparrow \text{PEPCK}$, $\downarrow \text{Pyruvate Kinase}$ via $\text{PFK1}$ feed-forward disruption).   - $\uparrow \text{FA}$ mobilization ($\uparrow \text{PKA}$ phosphorylation of perilipin and $\text{HSL}$).   - $\uparrow$ Ketogenesis as an alternate fuel for the brain.

Exercise Physiology and AMPK Signaling

• AMPK Activation:   - Vigorous exercise leads to high $\text{ATP}$ hydrolysis and increases in $\text{AMP}$.   - $\text{AMPK}$ enhances cardiac glycolysis and glucose transport (uptake for oxidation rather than storage).

• Enzyme Inactivation:   - $\text{AMPK}$ inactivates Fatty Acid Synthase, $\text{ACC1}$, $\text{HMGR}$, $\text{GPAT}$, and Glycogen Synthase.

• Regulation of $\beta$-oxidation:   - $\text{AMPK}$ phosphorylates and inactivates $\text{ACC1}$, reducing Malonyl-CoA levels.   - $\text{AMPK}$ activates malonyl-CoA decarboxylase.   - Low Malonyl-CoA relieves inhibition on $\text{CPT1}$, allowing $\text{FFA}$ entry into mitochondria for oxidation.

• Case Study 7: Athletes:   - Short Sprints ($100\,\text{m}$ dash): Relies on phosphocreatine and muscle glycogenolysis for immediate bursts.   - Marathons ($10,000\,\text{m}$ track): Relies on plasma glucose and $\text{TAG}$ hydrolysis (stimulated by epinephrine).   - Growth Hormone: Exercise serves as an adjunct diagnosis for growth hormone deficiency.

Fasting and Starvation States

• Basal State (Overnight Fast):   - Occurs after a $12\text{-hour}$ fast. Glucagon starts to rise as insulin falls.   - Glycogen stores are depleted after roughly $16\text{-hours}$.   - Glucose Shunting: Tissues with insulin-independent transporters ($\text{GLUT1}$ / $\text{GLUT2}$), like the brain and $\text{RBCs}$, preferentially receive blood glucose.   - $\text{RBCs}$ produce lactate, which returns to the liver for gluconeogenesis ($\text{Cori Cycle}$).

• Prolonged Fasting vs. 24-hour Fast (Table 4):   - After $24\text{-hours}$, the brain increases ketone body use and decreases glucose use.   - Gluconeogenesis and urea production eventually decrease to spare muscle protein degradation.

• Glyceroneogenesis:   - In adipocytes, $\text{PEPCK}$ converts non-carbohydrate precursors to $\text{DHAP}$, then to glycerol-3-phosphate via glycerol-3-phosphate dehydrogenase.   - Approximately $75\%$ of $\text{FFAs}$ are re-esterified into $\text{TAGs}$ during hydrolysis to preserve energy stores.

• Refeeding Syndrome (Case 12 & 10):   - Prolonged fasting requires careful refeeding to prevent dumping syndrome, osmotic diarrhea, and electrolyte imbalances. Phosphate must be reintroduced slowly.

Diabetes Mellitus (DM)

• Type 1 vs. Type 2 DM (Table 5):   - Type 1: Onset $< 20\,\text{years}$; autoimmune destruction of $\beta$-cells; insulin absent; ketoacidosis common; treated with insulin.   - Type 2: Onset $> 40\,\text{years}$; insulin resistance combined with impaired $\beta$-cells; ketoacidosis rare (except during severe infection); treated with oral drugs/insulin.

• Metabolic Alterations:   - Enhanced Processes: Glycogenolysis, Lipolysis (increased $\text{FFA}$ and glycerol), and Gluconeogenesis.   - The liver in uncontrolled $DM$ acts as if it is in a constant fasted state due to high glucagon effect.

• Pharmacological Interventions:   - Metformin (Biguanide): Activates $\text{AMPK}$ via $\text{LKB1}$; increases glucose uptake; decreases hepatic glucose production. Inhibits $\text{mTOR}$ translocation and $\text{CREB}$ activity.   - Sulfonylureas: Block $K^{+}$ channels in $\beta$-cells to stimulate insulin secretion.   - Thiazolidinediones (TZDs): Activate $\text{PPAR}\gamma$; regulate $\text{PEPCK}$ expression; improve insulin sensitivity.   - GLP-1 Modulators: Enhance insulin secretion.

Metabolic Changes in Pregnancy (Case 5)

• Hormonal Drivers:   - Progesterone: Promotes insulin resistance in muscle/adipocytes for the benefit of the fetus.   - HPL (Human Placental Lactogen): Reduces insulin sensitivity and induces lipolysis, raising maternal $\text{FFA}$ levels.   - Adiponectin: Low levels (hypoadiponectinemia) in early pregnancy serve as a predictive marker for Gestational Diabetes Mellitus ($\text{GDM}$).   - Inflammatory Cytokines: $\text{TNF-}\alpha$ has the strongest impact on causing late-pregnancy insulin resistance.

• Trimester Phases:   - 1st & 2nd Trimester (Anabolic): Increased synthesis of $\text{FFA}$, cholesterol, and $\text{TAGs}$.   - 3rd Trimester (Catabolic): Increased $\text{LPL}$ activity and constant lipolysis to ensure fetal nutrient supply.

Questions & Discussion

• Correct effect of exercise on AMPK?: Decreased fatty acid synthesis.

• What increases during starvation?: Usage of ketone bodies by the brain.

• What is NOT high during stress?: Insulin (Cortisol, Glucagon, and $\text{PEPCK}$ are high).

• Why cannot fats be converted to glucose?: Irreversible nature of pyruvate dehydrogenase ($\text{PDH}$), which prevents acetyl-CoA from becoming pyruvate for gluconeogenesis.

• Common degradation product of CHOs, fats, and proteins?: Acetyl CoA.